Bispecific antibodies and targeted cellular cytotoxicity: Ostuni (Brindisi), Italy, June 13 - 17, 1992
Gespeichert in:
Format: | Buch |
---|---|
Sprache: | English |
Veröffentlicht: |
New York, NY
Wiley-Liss
1992
|
Schriftenreihe: | International journal of cancer / Supplement
7 |
Schlagworte: | |
Beschreibung: | Literaturangaben |
Beschreibung: | 81 S. Ill., graph. Darst. |
Internformat
MARC
LEADER | 00000nam a2200000 cb4500 | ||
---|---|---|---|
001 | BV005881738 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | t | ||
008 | 921203s1992 ad|| |||| 10||| eng d | ||
035 | |a (OCoLC)231408607 | ||
035 | |a (DE-599)BVBBV005881738 | ||
040 | |a DE-604 |b ger |e rakddb | ||
041 | 0 | |a eng | |
049 | |a DE-19 |a DE-355 |a DE-12 |a DE-20 | ||
245 | 1 | 0 | |a Bispecific antibodies and targeted cellular cytotoxicity |b Ostuni (Brindisi), Italy, June 13 - 17, 1992 |c chairpersons: R. L. H. Bolhuis ... |
264 | 1 | |a New York, NY |b Wiley-Liss |c 1992 | |
300 | |a 81 S. |b Ill., graph. Darst. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
490 | 1 | |a International journal of cancer / Supplement |v 7 | |
500 | |a Literaturangaben | ||
650 | 0 | 7 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Cytotoxizität |0 (DE-588)4193696-6 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Antikörper |0 (DE-588)4002290-0 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Monoklonaler Antikörper |0 (DE-588)4040094-3 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Chemotherapie |0 (DE-588)4127083-6 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Arzneistoffträger |0 (DE-588)4278196-6 |2 gnd |9 rswk-swf |
655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1992 |z Ostuni |2 gnd-content | |
655 | 7 | |a Ostuni <1992> |2 gnd |9 rswk-swf | |
689 | 0 | 0 | |a Antikörper |0 (DE-588)4002290-0 |D s |
689 | 0 | 1 | |a Cytotoxizität |0 (DE-588)4193696-6 |D s |
689 | 0 | |5 DE-604 | |
689 | 1 | 0 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
689 | 1 | 1 | |a Chemotherapie |0 (DE-588)4127083-6 |D s |
689 | 1 | 2 | |a Monoklonaler Antikörper |0 (DE-588)4040094-3 |D s |
689 | 1 | 3 | |a Arzneistoffträger |0 (DE-588)4278196-6 |D s |
689 | 1 | |5 DE-604 | |
689 | 2 | 0 | |a Monoklonaler Antikörper |0 (DE-588)4040094-3 |D s |
689 | 2 | 1 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
689 | 2 | 2 | |a Ostuni <1992> |A f |
689 | 2 | |5 DE-604 | |
689 | 3 | 0 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
689 | 3 | 1 | |a Monoklonaler Antikörper |0 (DE-588)4040094-3 |D s |
689 | 3 | |5 DE-604 | |
700 | 1 | |a Bolhuis, Reinder L. |e Sonstige |4 oth | |
810 | 2 | |a Supplement |t International journal of cancer |v 7 |w (DE-604)BV004417939 |9 7 | |
999 | |a oai:aleph.bib-bvb.de:BVB01-003683144 |
Datensatz im Suchindex
_version_ | 1804120072274313216 |
---|---|
any_adam_object | |
building | Verbundindex |
bvnumber | BV005881738 |
ctrlnum | (OCoLC)231408607 (DE-599)BVBBV005881738 |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02171nam a2200553 cb4500</leader><controlfield tag="001">BV005881738</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">921203s1992 ad|| |||| 10||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)231408607</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV005881738</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-12</subfield><subfield code="a">DE-20</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Bispecific antibodies and targeted cellular cytotoxicity</subfield><subfield code="b">Ostuni (Brindisi), Italy, June 13 - 17, 1992</subfield><subfield code="c">chairpersons: R. L. H. Bolhuis ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York, NY</subfield><subfield code="b">Wiley-Liss</subfield><subfield code="c">1992</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">81 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">International journal of cancer / Supplement</subfield><subfield code="v">7</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Literaturangaben</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Cytotoxizität</subfield><subfield code="0">(DE-588)4193696-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Antikörper</subfield><subfield code="0">(DE-588)4002290-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Monoklonaler Antikörper</subfield><subfield code="0">(DE-588)4040094-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Chemotherapie</subfield><subfield code="0">(DE-588)4127083-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneistoffträger</subfield><subfield code="0">(DE-588)4278196-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1992</subfield><subfield code="z">Ostuni</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="a">Ostuni <1992></subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Antikörper</subfield><subfield code="0">(DE-588)4002290-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Cytotoxizität</subfield><subfield code="0">(DE-588)4193696-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Chemotherapie</subfield><subfield code="0">(DE-588)4127083-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Monoklonaler Antikörper</subfield><subfield code="0">(DE-588)4040094-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="3"><subfield code="a">Arzneistoffträger</subfield><subfield code="0">(DE-588)4278196-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Monoklonaler Antikörper</subfield><subfield code="0">(DE-588)4040094-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="2"><subfield code="a">Ostuni <1992></subfield><subfield code="A">f</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="3" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2="1"><subfield code="a">Monoklonaler Antikörper</subfield><subfield code="0">(DE-588)4040094-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bolhuis, Reinder L.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="810" ind1="2" ind2=" "><subfield code="a">Supplement</subfield><subfield code="t">International journal of cancer</subfield><subfield code="v">7</subfield><subfield code="w">(DE-604)BV004417939</subfield><subfield code="9">7</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-003683144</subfield></datafield></record></collection> |
genre | (DE-588)1071861417 Konferenzschrift 1992 Ostuni gnd-content Ostuni <1992> gnd |
genre_facet | Konferenzschrift 1992 Ostuni Ostuni <1992> |
id | DE-604.BV005881738 |
illustrated | Illustrated |
indexdate | 2024-07-09T16:36:16Z |
institution | BVB |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-003683144 |
oclc_num | 231408607 |
open_access_boolean | |
owner | DE-19 DE-BY-UBM DE-355 DE-BY-UBR DE-12 DE-20 |
owner_facet | DE-19 DE-BY-UBM DE-355 DE-BY-UBR DE-12 DE-20 |
physical | 81 S. Ill., graph. Darst. |
publishDate | 1992 |
publishDateSearch | 1992 |
publishDateSort | 1992 |
publisher | Wiley-Liss |
record_format | marc |
series2 | International journal of cancer / Supplement |
spelling | Bispecific antibodies and targeted cellular cytotoxicity Ostuni (Brindisi), Italy, June 13 - 17, 1992 chairpersons: R. L. H. Bolhuis ... New York, NY Wiley-Liss 1992 81 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier International journal of cancer / Supplement 7 Literaturangaben Krebs Medizin (DE-588)4073781-0 gnd rswk-swf Cytotoxizität (DE-588)4193696-6 gnd rswk-swf Antikörper (DE-588)4002290-0 gnd rswk-swf Monoklonaler Antikörper (DE-588)4040094-3 gnd rswk-swf Chemotherapie (DE-588)4127083-6 gnd rswk-swf Arzneistoffträger (DE-588)4278196-6 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1992 Ostuni gnd-content Ostuni <1992> gnd rswk-swf Antikörper (DE-588)4002290-0 s Cytotoxizität (DE-588)4193696-6 s DE-604 Krebs Medizin (DE-588)4073781-0 s Chemotherapie (DE-588)4127083-6 s Monoklonaler Antikörper (DE-588)4040094-3 s Arzneistoffträger (DE-588)4278196-6 s Ostuni <1992> f Bolhuis, Reinder L. Sonstige oth Supplement International journal of cancer 7 (DE-604)BV004417939 7 |
spellingShingle | Bispecific antibodies and targeted cellular cytotoxicity Ostuni (Brindisi), Italy, June 13 - 17, 1992 Krebs Medizin (DE-588)4073781-0 gnd Cytotoxizität (DE-588)4193696-6 gnd Antikörper (DE-588)4002290-0 gnd Monoklonaler Antikörper (DE-588)4040094-3 gnd Chemotherapie (DE-588)4127083-6 gnd Arzneistoffträger (DE-588)4278196-6 gnd |
subject_GND | (DE-588)4073781-0 (DE-588)4193696-6 (DE-588)4002290-0 (DE-588)4040094-3 (DE-588)4127083-6 (DE-588)4278196-6 (DE-588)1071861417 |
title | Bispecific antibodies and targeted cellular cytotoxicity Ostuni (Brindisi), Italy, June 13 - 17, 1992 |
title_auth | Bispecific antibodies and targeted cellular cytotoxicity Ostuni (Brindisi), Italy, June 13 - 17, 1992 |
title_exact_search | Bispecific antibodies and targeted cellular cytotoxicity Ostuni (Brindisi), Italy, June 13 - 17, 1992 |
title_full | Bispecific antibodies and targeted cellular cytotoxicity Ostuni (Brindisi), Italy, June 13 - 17, 1992 chairpersons: R. L. H. Bolhuis ... |
title_fullStr | Bispecific antibodies and targeted cellular cytotoxicity Ostuni (Brindisi), Italy, June 13 - 17, 1992 chairpersons: R. L. H. Bolhuis ... |
title_full_unstemmed | Bispecific antibodies and targeted cellular cytotoxicity Ostuni (Brindisi), Italy, June 13 - 17, 1992 chairpersons: R. L. H. Bolhuis ... |
title_short | Bispecific antibodies and targeted cellular cytotoxicity |
title_sort | bispecific antibodies and targeted cellular cytotoxicity ostuni brindisi italy june 13 17 1992 |
title_sub | Ostuni (Brindisi), Italy, June 13 - 17, 1992 |
topic | Krebs Medizin (DE-588)4073781-0 gnd Cytotoxizität (DE-588)4193696-6 gnd Antikörper (DE-588)4002290-0 gnd Monoklonaler Antikörper (DE-588)4040094-3 gnd Chemotherapie (DE-588)4127083-6 gnd Arzneistoffträger (DE-588)4278196-6 gnd |
topic_facet | Krebs Medizin Cytotoxizität Antikörper Monoklonaler Antikörper Chemotherapie Arzneistoffträger Konferenzschrift 1992 Ostuni Ostuni <1992> |
volume_link | (DE-604)BV004417939 |
work_keys_str_mv | AT bolhuisreinderl bispecificantibodiesandtargetedcellularcytotoxicityostunibrindisiitalyjune13171992 |